1,300 Guyanese women supporting Exxon activities onshore and offshore

Must Read

OilNOW
OilNOW
OilNOW is an online-based Information and Resource Centre

New half-year local content data from ExxonMobil Guyana Limited (EMGL) indicate that 1,300 Guyanese women are supporting the company’s operations both on and offshore, in the South American country.

EMGL said that Guyanese represent 69% of its overall workforce. 

A total of 5,900 Guyanese workers supported Exxon and its reporting contractors in H1 2023. More than 3,500 are based offshore. 

While this is notable, there have been public complaints that expatriates are being paid higher revenues than Guyanese employed with Exxon, and that the expatriate budget is outsized in comparison to the budget for Guyanese employees.

Opportunities for women through the oil and gas sector | OilNOW

EMGL reported that since 2015, the company and its contractors have spent more than US$1.2 billion with Guyanese suppliers. 

The company said it also engaged with 1,500 unique Guyanese suppliers; more than US$280 million was spent with those suppliers, up 45% from H1 2022. 

“Claim your seat at the table” – British envoy urges as Women in Energy group launches | OilNOW

The diverse supplier base ranges from services that include structural fabrication, accounting, legal, marketing, catering, facilities management, recruitment, medical, security, logistics and transportation. 

Additionally, EMGL said it and its Stabroek Block co-venturers have committed to invest US$40 billion in five offshore developments. 

Guyanese authorities have been encouraging the equipment of women with the skills needed to tap into the growing opportunities in the nation’s booming economy. Since 2015, a series of major oil discoveries and the start of production have propelled the small South American country to become the fastest-growing economy in the world.

- ADVERTISEMENT -
spot_img

Partnered Events

Latest News

Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel...

More Articles Like This